genomic deletion 11q
Showing 1 - 25 of 1,560
Relapsed Chronic Lymphocytic Leukemia Trial in Ann Arbor (Metformin)
Recruiting
- Relapsed Chronic Lymphocytic Leukemia
-
Ann Arbor, MichiganUniversity of Michigan Comprehensive Cancer Center
May 11, 2022
22Q11 Deletion Syndrome, tACS Trial (at-home tACS using Starstim-Home tES)
Not yet recruiting
- 22Q11 Deletion Syndrome
- tACS
- at-home tACS using Starstim-Home tES
- (no location specified)
Dec 15, 2022
22Q11 Deletion Syndrome Trial (Aware Program)
Not yet recruiting
- 22Q11 Deletion Syndrome
- Aware Program
- (no location specified)
Apr 28, 2023
Examining Genetic Factors That Affect Severity of 22q11.2
Recruiting
- DiGeorge Syndrome
- 22q11.2 Deletion Syndrome
-
New York, New York
- +1 more
Jul 18, 2022
22q11.2 Deletion Syndrome Trial in Geneva (Concerta)
Recruiting
- 22q11.2 Deletion Syndrome
-
Geneva, SwitzerlandDevelopmental imaging and psychopathology lab
Mar 29, 2022
22q11.2 Deletion Syndrome Trial in Geneva (Risperdal, Placebo)
Terminated
- 22q11.2 Deletion Syndrome
- Risperdal
- Placebo
-
Geneva, SwitzerlandDevelopmental imaging and psychopathology lab
Mar 29, 2022
22q11.2 Deletion Syndrome Trial in Philadelphia (NFC-1)
Completed
- 22q11.2 Deletion Syndrome
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Mar 24, 2022
People Who Have Genetic Changes and Features of Autism: Simons
Recruiting
- 16P11.2 Deletion Syndrome
- +184 more
-
New York, New York
- +1 more
Jan 6, 2023
Children at Increased Risk for Scoliosis Development
Recruiting
- Adolescent Idiopathic Scoliosis
- 22q11.2 Deletion Syndrome
- MRI
- +2 more
-
Utrecht, NetherlandsUMC Utrecht
Jun 20, 2023
Trisomy 21, 18, 13 and 22q11.2 Deletion Syndrome
Recruiting
- Pregnancy
- cfDNA screening
-
Tuebingen, GermanyUniversity Hospital Tuebingen, Department of Women's Health
Jan 11, 2022
22q11.2 Deletion Syndrome Trial in Lyon (neuropsychological testing, questionnaires and experimental tasks)
Recruiting
- 22q11.2 Deletion Syndrome
- neuropsychological testing, questionnaires and experimental tasks
-
Lyon, Rhone Alpes, FranceHopital Vinatier
Jan 26, 2022
Genetic Modifiers for 22q11.2 Syndrome
Completed
- 22q11.2 Deletion Syndrome
- Observation
-
Syracuse, New YorkVCFS International Center
Oct 19, 2021
Advanced Data Analytics in Genetic Conditions
Not yet recruiting
- Neurofibromatosis
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Neurodevelopmental Disorders, Autism, Autism Spectrum Disorder Trial in Canada (Sertraline, Placebo)
Not yet recruiting
- Neurodevelopmental Disorders
- +25 more
- Sertraline
- Placebo
-
Calgary, Alberta, Canada
- +6 more
Oct 11, 2023
Prenatal Examination of Deletion 22q11 Syndrome : Thymic
Completed
- 22q11 Deletion Syndrome Di George Syndrome
-
Nîmes, FranceCHUNimes
Jan 26, 2021
Fragile X Syndrome, Angelman Syndrome, Prader-Willi Syndrome Trial in Research Triangle Park (Parent-Infant Inter(X)action
Enrolling by invitation
- Fragile X Syndrome
- +13 more
- Parent-Infant Inter(X)action Intervention (PIXI)
-
Research Triangle Park, North CarolinaRTI International
Feb 23, 2022
Non-Invasive Chromosomal Evaluation of 22q11.2
Completed
- 22q.11.2 Deletion/Duplication
-
Brussles, BelgiumThe Fetal Medicine Foundation Belgium
Apr 28, 2020
NSCLC Trial in Guangzhou (Avitinib Maleate, Afatinib, Crizotinib)
Recruiting
- Carcinoma, Non-Small-Cell Lung
- Avitinib Maleate
- +13 more
-
Guangzhou, Guangdong, ChinaGuangdong Lung Cancer Institute, Guangdong Provincial People's H
Dec 3, 2022
22q11 Deletion Syndrome, DiGeorge Syndrome, Trisomy 21 Trial in Worldwide
Completed
- 22q11 Deletion Syndrome
- +10 more
-
San Francisco, California
- +20 more
Jan 27, 2021
GROWing Up With Rare GENEtic Syndromes
Recruiting
- Prader-Willi Syndrome
- +32 more
- Retrospective file studies
-
Rotterdam, Zuid-Holland, NetherlandsErasmus Medical Center
Jul 3, 2020
Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7) Trial in United
Completed
- Adult Acute Basophilic Leukemia
- +16 more
-
Little Rock, Arkansas
- +53 more
Jan 13, 2022
Leukemia Trial in Houston (Cyclophosphamide, Rituximab, Sapacitabine)
Terminated
- Leukemia
- Cyclophosphamide
- +2 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Aug 15, 2019
Genomic and Dietary Aspects in Gastric Cancer Risk
Not yet recruiting
- Gastric Cancer
-
Roma, Italia, ItalyDipartimento Universitario di Scienze della Vita e Sanità Pubbli
Jun 28, 2023